Stericycle, Inc. - Common Stock Azioni (NASDAQ: SRCL)

Ultime notizie per Stericycle, Inc. - Common Stock (NASDAQ:SRCL) Azioni

Stericycle

Stericycle, Inc. - Common Stock

Chewy Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CHWY#NYSE">CHWY</a>) stock picked up momentum on Monday. The company announced Friday that it would replace Stericycle Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SRCL#NASDAQ">SRCL</a>) in the S&amp;P MidCap 400, effective before the opening of <a target="_blank" href="https://www.benzinga.com/pressreleases/24/11/n41697830/chewy-set-to-join-s-p-midcap-400" rel="noreferrer noopener">trading on&nbsp;Wednesday, November 6</a>.
S&amp;P 500&#8217;s Waste Management Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WM#NYSE">WM</a>) will acquire Stericycle in a deal, pending final closing conditions.
Goldman Sachs <a target="_blank" href="https://www.benzinga.com/analyst-ratings/analyst-color/24/10/41402089/goldman-sachs-highlights-20-top-short-squeeze-opportunities-for-q3-earnings-season" rel="noreferrer noopener">has pinpointed 20 stocks</a>, including Chewy, with high short interest that could be poised for a short squeeze if upcoming earnings surpass expectations, presenting trading opportunities.
Also Read: <a target="_blank" href="https://www.benzinga.com/government/24/09/41100310/chewy-insider-penalized-by-sec-for-trading-on-confidential-pet-insurance-deal-info" rel="noreferrer noopener">Chewy Insider Penalized by SEC for Trading on Confidential Pet Insurance Deal Info</a>
Analyst John Marshall and his team noted that continued short-covering could drive substantial gains for these stocks. Goldman&#8217;s analysts also mentioned that heavily shorted stocks frequently experience &#8220;relief rallies&#8221; around earnings, where better-than-expected results boost share prices by easing bearish sentiment.
In October, meme stock trader Keith Gill, also known as &#8220;Roaring Kitty,&#8221; exited his position in the <a target="_blank" href="https://www.benzinga.com/news/24/10/41614177/roaring-kitty-puts-chewy-stock-in-the-litter-box-gamestop-shares-move-higher-after-hours" rel="noreferrer noopener">online pet retailer</a>. According to the <a target="_blank" href="https://www.sec.gov/Archives/edgar/data/1871280/000110465924112245/tm2427027d1_sc13ga.htm" rel="noreferrer noopener">13G filing</a> with the SEC, Gill sold his entire stake in Chewy. The filing indicates Gill had a 0% stake in the pet retailer as of September 30.
Chewy reported <a target="_blank" href="https://www.benzinga.com/news/earnings/24/08/40599759/pet-supply-retailer-chewys-q2-earnings-profit-edges-out-expectation-sales-per-active-customer-hits-" rel="noreferrer noopener">second-quarter sales</a> of $2.86 billion, up 2.6%, versus the consensus of $2.86 billion and the management guidance&nbsp;of $2.84 billion–$2.86 billion.
Net Sales Per Active Customer increased 6.2% to $565. Chewy&nbsp;forecasts&nbsp;third-quarter sales of $2.84 billion–$2.86 billion, up by 3%-4% versus the consensus of $2.87 billion.
Chewy&nbsp;stock gained over 21% year-to-date. Investors can gain exposure to the stock through Amplify Online Retail ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IBUY#NYSE">IBUY</a>) and ProShares Online Retail ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ONLN#NYSE">ONLN</a>)
Price Action: CHWY stock is up 5.90% at $28.72 premarket at last check Monday.
Also Read:
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/11/41692232/ubers-q3-review-analysts-see-opportunity-amid-growth-slowdown-strong-margins-and-ex" target="_blank" rel="noreferrer noopener">Uber&#8217;s Q3 Review: Analysts See Opportunity Amid Growth Slowdown, Strong Margins, And Expanding Autonomous Vehicle Partnerships</a></li>
</ul>
Image via Chewy

News

Movers

CHWY

IBUY

ONLN

SRCL

Roaring Kitty Stock Chewy Set to Join S&P MidCap 400 Index, Will Replace Stericycle

With U.S. stock futures trading mixed this morning on Monday, some of the stocks that may grab investor focus today are as follows:
<ul>
<li>Wall Street expects Constellation Energy Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CEG#NASDAQ">CEG</a>) to report quarterly earnings at $2.64 per share on revenue of $5.71 billion before the opening bell, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>. Constellation Energy shares fell 5.5% to $243.99 in after-hours trading.</li>
<li>Analysts expect Marriott International, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MAR#NASDAQ">MAR</a>) to post quarterly earnings at $2.31 per share on revenue of $6.27 billion. The company will release earnings before the markets open. Marriott shares gained 0.5% to $261.75 in after-hours trading.</li>
<li>Chewy Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CHWY#NYSE">CHWY</a>) will replace Stericycle Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SRCL#NASDAQ">SRCL</a>) in the S&amp;P MidCap 400 before the opening bell on Wednesday, Nov. 6. Waste Management Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WM#NYSE">WM</a>) is acquiring Stericycle in a transaction expected to be completed soon. Chewy shares surged 5.1% to $28.51 in the after-hours trading session.</li>
</ul>
Check out our <a href="https://www.benzinga.com/premarket/">premarket coverage here</a>
<ul>
<li>After the markets close, Wynn Resorts, Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WYNN#NASDAQ">WYNN</a>) is projected to report quarterly earnings at $1.01 per share on revenue of $1.73 billion. Wynn Resorts shares gained 0.2% to $95.87 in the after-hours trading session.</li>
<li>Analysts expect Celanese Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CE#NYSE">CE</a>) to report quarterly earnings at $2.85 per share on revenue of $2.7 billion after the closing bell. Celanese shares gained 1.5% to $126.70 in after-hours trading.</li>
</ul>
Check This Out:
<ul>
<li><a href="https://www.benzinga.com/news/24/11/41685620/top-3-energy-stocks-that-are-preparing-to-pump-in-november">Top 3 Energy Stocks That Are Preparing To Pump In November</a></li>
</ul>
Photo courtesy: Shutterstock

Earnings

Pre-Market Outlook

Markets

Trading Ideas

WYNN

Marriott, Constellation Energy And 3 Stocks To Watch Heading Into Monday

<a href="https://www.spglobal.com/spdji/en/documents/indexnews/announcements/20241101-1475163/1475163_srcl4.pdf" title="https://www.spglobal.com/spdji/en/documents/indexnews/announcements/20241101-1475163/1475163_srcl4.pdf">https://www.spglobal.com/spdji/en/documents/indexnews/announcements/20241101-1475163/1475163_srcl4.pdf</a>

Chewy Set to Join S&P MidCap 400; Chewy Will Replace Stericycle Inc In The S&P MidCap 400 Effective Prior To The Opening Of Trading On Wednesday, November 6

Some holders of a Stericycle Inc. bond have engaged legal counsel to negotiate better terms for a debt-exchange offer made by Waste Management Inc., which agreed in June to buy the medical-waste firm.&nbsp;
&nbsp;
<a href="https://www.bloomberg.com/news/articles/2024-09-18/stericycle-bondholders-seek-more-cash-from-exchange-offer?sref=y3YMCJ4e&amp;embedded-checkout=true" title="https://www.bloomberg.com/news/articles/2024-09-18/stericycle-bondholders-seek-more-cash-from-exchange-offer?sref=y3YMCJ4e&amp;embedded-checkout=true">https://www.bloomberg.com/news/articles/2024-09-18/stericycle-bondholders-seek-more-cash-from-exchange-offer?sref=y3YMCJ4e&amp;embedded-checkout=true</a>

'Stericycle Bondholders Seek More Cash From Exchange Offer' - Bloomberg

Legal

Stericycle Says Merger With Waste Management Got UK Foreign Direct Investment Approval, Expects Merger To Close As Early As Q4 Of 2024

Waste Management, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WM#NYSE">WM</a>) shares are trading lower after the company reported <a target="_blank" href="https://www.benzinga.com/pressreleases/24/07/b39943210/wm-announces-second-quarter-2024-earnings" rel="noreferrer noopener">worse-than-expected second-quarter financial results</a>.
Sales&nbsp;of $5.402 billion missed the consensus of&nbsp;$5.427 billion. Total company revenue grew&nbsp;5.5%, driven primarily by core price of&nbsp;6.8%&nbsp;and increases in the value of the recycled commodities the company sells.
Collection and Disposal yield stood at 4.6%, and Collection and Disposal volume declined 0.3% in the quarter.
Adjusted operating EBITDA grew 10.3% Y/Y to $1.62 billion, with a 130 basis point margin Y/Y expansion to 30.0%.
Adjusted operating EBITDA in the Collection and Disposal business rose $203 million to $1.84 billion, with a margin of 37.3% in the quarter.
Adjusted EPS of $1.82 <a href="https://www.benzinga.com/earnings" target="_blank" rel="noreferrer noopener">missed the consensus of $1.83</a>.
In the first half of the year, net cash from operating activities surged 21.6% to $2.52 billion and free cash flow before high-return sustainability investments increased 41.1% to $1.63 billion.
Jim Fish, WM&#8217;s President and Chief Executive Officer, said, &#8220;Revenue grew by 5.5% this quarter, and our disciplined focus on leveraging our people, technology and processes to reduce our cost to serve continued to drive margin expansion.&#8221;
&#8220;In our renewable energy business, we are scheduled to complete a total of five projects in 2024, with an additional nine projects currently under construction.&#8221;
Outlook: Waste Management reiterated its FY24 outlook of $6.375 billion–$6.525 billion in adjusted operating EBITDA and $2.0 billion–$2.15 billion in free cash flow including sustainability growth investments.
Last month, Waste Management inked a deal to acquire Stericycle, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SRCL#NASDAQ">SRCL</a>) for&nbsp;<a target="_blank" href="https://www.benzinga.com/markets/equities/24/06/39137673/waste-management-to-acquire-stericycle-for-62-00share-in-cash-at-20-premium" rel="noreferrer noopener">approximately $7.2 billion, including debt</a>.
Investors can gain exposure to the stock via&nbsp;VanEck Environmental Services ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EVX#NYSE">EVX</a>) and IShares U.S. Utilities ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IDU#NYSE">IDU</a>).
Price Action: WM shares are down 6.85% at $202.48 at the last check Thursday.
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Equities

Guidance

Market Vectors Environmental Services Index Fund

iShares Trust Dow Jones US Utilities Sector Index Fund

Why Waste Management Shares Are Diving Today

As of June 12, 2024, four stocks in the industrials sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
The RSI is a momentum indicator, which compares a stock&#8217;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#8217;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered overbought when the <a href="https://www.benzinga.com/topic/rsi">RSI is above 70</a>, according to <a href="https://pro.benzinga.com/">Benzinga Pro</a>. 
Here's the latest list of major overbought players in this sector.
<h3 class="wp-block-heading">American Superconductor Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMSC#NASDAQ">AMSC</a>)</h3>
<ul>
<li>On May 29, American Superconductor posted strong fourth-quarter financial results. "Our fourth quarter results exceeded our forecast by nearly every measure, with growth in both our Grid and Wind segments and a third consecutive quarter of non-GAAP net income. During the fourth quarter, we booked $39 million in orders, and our backlog at year-end stood at $140 million," said Daniel P. McGahn, President and CEO of AMSC. The company's stock gained around 57% over the past month and has a <a href="https://www.benzinga.com/quote/AMSC">52-week high of $22.50</a>.</li>
<li>RSI Value: 76.46&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li>
<li>AMSC Price Action: Shares of American Superconductor fell 0.5% to close at $21.96 on Tuesday.</li>
</ul>
<h3 class="wp-block-heading">Verisk Analytics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRSK#NASDAQ">VRSK</a>)</h3>
<ul>
<li>On May 1, Verisk Analytics reported better-than-expected quarterly financial results. Lee Shavel, president and CEO, Verisk, said, &#8220;I am very pleased to share that 2024 is off to a solid start at Verisk. We are executing our growth strategy with our powerful economic model that creates value through investment in data, new technologies, and strategic engagement with our clients across the entire insurance ecosystem.&#8221; The company's stock gained around 7% over the past month and <a href="https://www.benzinga.com/quote/VRSK">has a 52-week high</a> of $264.94.</li>
<li>RSI Value: 73.16</li>
<li>VRSK Price Action: Shares of Verisk Analytics rose 0.5% to close at $264.67 on Tuesday.</li>
</ul>
<h3 class="wp-block-heading">Stericycle Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SRCL#NASDAQ">SRCL</a>)</h3>
<ul>
<li>On June 3, Stericycle announced that it entered into a definitive agreement to be acquired by Waste Management. The company's stock gained around 26% over the past month and has a <a href="https://www.benzinga.com/quote/SRCL">52-week high</a> of $59.45.</li>
<li>RSI Value: 74.99</li>
<li>SRCL Price Action: Shares of Stericycle fell 0.4% to close at $58.77 on Tuesday.</li>
</ul>
<h3 class="wp-block-heading">ABM Industries Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABM#NYSE">ABM</a>)</h3>
<ul>
<li>On June 6, ABM reported second-quarter sales growth of 1.7% year-over-year to $2.02 billion, beating the consensus of $2 billion. &#8220;ABM&#8217;s service breadth, people, and customer focus, as well as the investments we have made in technology, have enabled us to perform well in challenging market conditions. Going forward, we expect to further leverage our investments and strong free cash flow to self-fund growth and pursue margin expansion opportunities, while at the same time consistently returning capital and building long-term stockholder value,&#8221; commented Scott Salmirs, President &amp; Chief Executive Officer. The company's stock jumped around 10% over the past month and has a 52-week high is $53.05.</li>
<li>RSI Value: 72.91</li>
<li>ABM Price Action: Shares of ABM gained 1% to close at $50.61 on Tuesday.</li>
</ul>
Now Read This: <a href="https://www.benzinga.com/markets/equities/24/06/39285318/s-p-500-nasdaq-hit-record-highs-as-apple-shares-surge-fear-and-greed-index-shows-progress-amid-i">S&amp;P 500, Nasdaq Hit Record Highs As Apple Shares Surge: Fear And Greed Index Shows Progress Amid Improving Market Sentiment</a>

Short Ideas

AMSC

VRSK

Top 4 Industrials Stocks That May Crash This Quarter

In the last three months, 6 analysts have published ratings on Stericycle (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SRCL#NASDAQ">SRCL</a>), offering a diverse range of perspectives from bullish to bearish.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
Analysts have set 12-month price targets for Stericycle, revealing an average target of $73.33, a high estimate of $142.00, and a low estimate of $50.00. A negative shift in sentiment is evident as analysts have decreased the average price target by 1.7%. 
<img src="https://www.benzinga.com/files/images/story/2024/1717524047_0.png" alt="price target chart" />
<h2>Understanding Analyst Ratings: A Comprehensive Breakdown</h2>
In examining recent analyst actions, we gain insights into how financial experts perceive Stericycle. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Jade Rahmani</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Raises</td>
<td>Outperform</td>
<td>$142.00</td>
<td>$135.00</td>
</tr>
<tr>
<td>Sean Dodge</td>
<td>RBC Capital</td>
<td>Lowers</td>
<td>Sector Perform</td>
<td>$62.00</td>
<td>$69.00</td>
</tr>
<tr>
<td>Tobey Sommer</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Hold</td>
<td>$62.00</td>
<td>$50.00</td>
</tr>
<tr>
<td>Tobey Sommer</td>
<td>Truist Securities</td>
<td>Lowers</td>
<td>Hold</td>
<td>$50.00</td>
<td>$57.00</td>
</tr>
<tr>
<td>David Manthey</td>
<td>Baird</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$55.00</td>
<td>$62.00</td>
</tr>
<tr>
<td>Sean Dodge</td>
<td>RBC Capital</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$69.00</td>
<td>-</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Stericycle. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of Stericycle compared to the broader market.</li>
<li>Price Targets: Analysts explore the dynamics of price targets, providing estimates for the future value of Stericycle's stock. This examination reveals shifts in analysts' expectations over time.</li>
</ul>
Navigating through these analyst evaluations alongside other financial indicators can contribute to a holistic understanding of Stericycle's market standing. Stay informed and make data-driven decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/SRCL/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Stericycle analyst ratings.</a>
<h2>Delving into Stericycle's Background</h2>
Stericycle is the largest provider of medical waste disposal and data destruction (primarily paper shredding) services in the United States. Its next-closest national competitor in medical waste disposal is Sharps Compliance, which generated $76 million of sales in fiscal 2021 before its 2022 acquisition (about 4% of Stericycle's global regulated waste and compliance revenue). Stericycle's data destruction business, Shred-It, is about twice the size of its closest competitor (Iron Mountain's information destruction segment). Stericycle has a global presence, with about 20% of its revenue earned outside North America.
<h3>Stericycle: A Financial Overview</h3>
Market Capitalization Analysis: Positioned below industry benchmarks, the company's market capitalization faces constraints in size. This could be influenced by factors such as growth expectations or operational capacity.
Revenue Challenges: Stericycle's revenue growth over 3 months faced difficulties. As of 31 March, 2024, the company experienced a decline of approximately -2.83%. This indicates a decrease in top-line earnings. When compared to others in the Industrials sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: Stericycle's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 1.97% net margin, the company effectively manages costs and achieves strong profitability.
Return on Equity (ROE): The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of 0.52%, the company showcases effective utilization of equity capital.
Return on Assets (ROA): Stericycle's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of 0.24%, the company showcases efficient use of assets and strong financial health.
Debt Management: Stericycle's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.77.
<h2>Analyst Ratings: What Are They?</h2>
Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Analyst Ratings

What Analysts Are Saying About Stericycle Stock

Keefe, Bruyette &amp; Woods analyst Jade Rahmani maintains Stericycle (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SRCL#NASDAQ">SRCL</a>) with a Outperform and raises the price target from $135 to $142.

Price Target

Keefe, Bruyette & Woods Maintains Outperform on Stericycle, Raises Price Target to $142

RBC Capital analyst Sean Dodge downgrades Stericycle (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SRCL#NASDAQ">SRCL</a>) from Outperform to Sector Perform and lowers the price target from $69 to $62.

Downgrades

RBC Capital Downgrades Stericycle to Sector Perform, Lowers Price Target to $62

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-ratings/">analyst ratings page</a>.
<ul>
<li>Keybanc cut the price target for GitLab Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GTLB#NASDAQ">GTLB</a>) from $70 to $62. Keybanc analyst Jason Celino maintained an Overweight rating. GitLab shares fell 0.3% to close at $47.07 on Monday. <a href="https://www.benzinga.com/quote/GTLB/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Redburn Atlantic boosted the price target for Upstart Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UPST#NASDAQ">UPST</a>) from $22.5 to $25.5. Redburn Atlantic analyst Simon Clinch upgraded the stock from Sell to Neutral. Upstart shares fell 2.4% to close at $24.12 on Monday. <a href="https://www.benzinga.com/quote/UPST/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Mizuho boosted NVIDIA Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) price target from $1,180 to $1,275. Mizuho analyst Vijay Rakesh maintained a Buy rating. NVIDIA shares rose 4.9% to close at $1,150.00 on Monday. <a href="https://www.benzinga.com/quote/NVDA/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Morgan Stanley increased the price target for HEICO Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HEI#NYSE">HEI</a>) from $178 to $225. Morgan Stanley analyst Kristine Liwag upgraded the stock from Underweight to Equal-Weight. HEICO shares rose 0.3% to close at $222.48 on Monday. <a href="https://www.benzinga.com/quote/HEI/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Keefe, Bruyette &amp; Woods increased Toll Brothers, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TOL#NYSE">TOL</a>) price target from $135 to $142. Keefe, Bruyette &amp; Woods analyst Jade Rahmani maintained an Outperform rating. Toll Brothers shares fell 1.3% to close at $120.03 on Monday. <a href="https://www.benzinga.com/quote/TOL/analyst-ratings">See how other analysts view this stock.</a></li>
<li>JMP Securities boosted HealthEquity, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HQY#NASDAQ">HQY</a>) price target from $101 to $105. JMP Securities analyst Constantine Davides maintained a Market Outperform rating. HealthEquity shares fell 0.6% to close at $81.22 on Monday. <a href="https://www.benzinga.com/quote/HQY/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Oppenheimer raised the price target for Crinetics Pharmaceuticals Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRNX#NASDAQ">CRNX</a>) from $55 to $74. Oppenheimer analyst Leland Gershell maintained an Outperform rating. Crinetics Pharmaceuticals shares gained 4.2% to close at $46.28 on Monday. <a href="https://www.benzinga.com/quote/CRNX/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Mizuho cut Autodesk Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADSK#NASDAQ">ADSK</a>) price target from $270 to $230. Mizuho analyst Matthew Broome maintained a Neutral rating. Autodesk shares rose 4.6% to close at $210.82 on Monday. <a href="https://www.benzinga.com/quote/ADSK/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Truist Securities raised Stericycle Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SRCL#NASDAQ">SRCL</a>) price target from $50 to $62 Truist Securities analyst Tobey Sommer maintained a Hold rating. Stericycle shares jumped 14.6% to close at $59.05 on Monday. <a href="https://www.benzinga.com/quote/SRCL/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Piper Sandler boosted Bank of America Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BAC#NYSE">BAC</a>) price target from $35 to $37. Piper Sandler analyst Scott Siefers maintained an Underweight rating. Bank of America shares fell 0.3% to close at $39.88 on Monday. <a href="https://www.benzinga.com/quote/BAC/analyst-ratings">See how other analysts view this stock.</a></li>
</ul>
Check This Out: <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/06/39156066/top-3-financial-stocks-youll-regret-missing-this-quarter">Top 3 Financial Stocks You&#8217;ll Regret Missing This Quarter</a>

ADSK

CRNX

GTLB

NVDA

UPST

Nvidia To Rally Around 11%? Here Are 10 Top Analyst Forecasts For Tuesday

Truist Securities analyst Tobey Sommer maintains Stericycle (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SRCL#NASDAQ">SRCL</a>) with a Hold and raises the price target from $50 to $62.

Truist Securities Maintains Hold on Stericycle, Raises Price Target to $62

Shares of Science Applications International Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SAIC#NASDAQ">SAIC</a>) declined 11% to $119.91 following <a href="https://www.benzinga.com/news/earnings/24/06/39136938/science-applications-international-optimistic-about-hitting-annual-outlook-despite-q1-revenue-dip-s">first-quarter results.</a>
SAIC reported a 9% revenue decline year over year in the fiscal first quarter of 2025 to $1.847 billion, marginally beating the analyst consensus estimate of $1.844 billion. Adjusted EPS of $1.92 was in line with the analyst consensus estimate, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
SAIC shares dipped 11% to $119.91 on Monday.
Here are some other stocks moving in today&#8217;s mid-day session.
<h3 class="wp-block-heading">Gainers</h3>
<ul>
<li>Microbot Medical Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MBOT#NASDAQ">MBOT</a>) jumped 92.5% to $1.9301 after the company received FDA approval to proceed with its pivotal human clinical trial.</li>
<li>Bio-Path Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BPTH#NASDAQ">BPTH</a>) shares jumped 75% to $3.62. Bio-Path presented interim results from Phase 2 study of Prexigebersen (BP1001) in combination with decitabine and venetoclax for acute myeloid leukemia at the American Society Of Clinical Oncology Annual Meeting.</li>
<li>GameStop Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GME#NYSE">GME</a>) shares climbed 34.5% to $31.13 after Roaring Kitty on a Reddit post, shared his position on the stock.</li>
<li>Professional Diversity Network, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IPDN#NASDAQ">IPDN</a>) gained 28.5% to $0.65. Professional Diversity Network recently named Megan Bozzuto as interim CFO.</li>
<li>MarineMax, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HZO#NYSE">HZO</a>) gained 27% to $36.16. OneWater Marine Inc. is reportedly said to be in advanced discussions to acquire MarineMax.</li>
<li>Crown ElectroKinetics Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRKN#NASDAQ">CRKN</a>) shares rose 27% to $0.1271 after dipping 12% on Friday.</li>
<li>MingZhu Logistics Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/YGMZ#NASDAQ">YGMZ</a>) climbed 26.5% to $0.4425 after the company reported an agreement to acquire Oxylus Global.</li>
<li>Dogness (International) Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DOGZ#NASDAQ">DOGZ</a>) gained 23.5% to $13.65</li>
<li>Affimed N.V. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AFMD#NASDAQ">AFMD</a>) gained 22.2% to $5.25 as the company issued follow-up data of AFM24 plus atezolizumab showing durable responses in heavily pretreated NSCLC EGFR wild-type patients and positive initial data from the NSCLC EGFR mutant cohort.</li>
<li>Concord Medical Services Holdings Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CCM#NYSE">CCM</a>) rose 17.6% to $0.5883.</li>
<li>MacroGenics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MGNX#NASDAQ">MGNX</a>) rose 17.5% to $4.8001.</li>
<li>Personalis, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PSNL#NASDAQ">PSNL</a>) gained 17.5% to $1.5282.</li>
<li>Liquidia Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LQDA#NASDAQ">LQDA</a>) gained 16.8% to $15.03 as the company said District Court issued favorable ruling and denied United Therapeutics&#8217; request to block YUTREPIA&#x2122; launch.</li>
<li>Olema Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OLMA#NASDAQ">OLMA</a>) rose 15.5% to $11.18.</li>
<li>Stericycle, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SRCL#NASDAQ">SRCL</a>) gained 15% to $59.28 after the company announced that it entered into a definitive agreement to be acquired by Waste Management.</li>
<li>Precigen, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PGEN#NASDAQ">PGEN</a>) rose 15% to $1.61 after reporting study data for PRGN-2012 for recurrent respiratory papillomatosis patients.</li>
<li>Coherent Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COHR#NASDAQ">COHR</a>) gained 13.4% to $64.71 after the company announced the appointment of Jim Anderson as CEO.</li>
<li>CG Oncology, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGON#NASDAQ">CGON</a>) rose 11.8% to $36.34</li>
<li>Structure Therapeutics Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GPCR#NASDAQ">GPCR</a>) rose 11.8% to $38.25 after the company reported 12-week results for obesity drug GSBR-1290, achieving significant weight loss.</li>
<li>AMC Entertainment Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMC#NYSE">AMC</a>) gained 11.6% to $4.8330. The resumption of the meme rally came on the back of Keith Gill, also known as "Roaring Kitty," disclosing a substantial position in GameStop on the r/Superstonk Reddit forum.</li>
<li>Novavax, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVAX#NASDAQ">NVAX</a>) gained 10.7% to $16.65.</li>
<li>Telephone and Data Systems, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TDS#NYSE">TDS</a>) rose 9% to $21.67 as the company agreed to sell its wholly owned subsidiaries OneNeck IT Solutions and OneNeck Data Center to US Signal Company, LLC.</li>
<li>Faraday Future Intelligent Electric Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FFIE#NASDAQ">FFIE</a>) shares gained 8.8% to $0.6348 after gaining over 3% on Friday. </li>
<li>Autodesk, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADSK#NASDAQ">ADSK</a>) gained 8.3% to $218.39 after the company issued preliminary results and said there will be no restatement or adjustment of any audited or unaudited financial statements.</li>
<li>Molecular Partners AG (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MOLN#NASDAQ">MOLN</a>) shares climbed 8.2% to $4.0699. Molecular Partners presented data from completed Phase 1 trial of MP0317 monotherapy in advanced solid tumors at ASCO 2024.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul>
<li>CalAmp Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CAMP#NASDAQ">CAMP</a>) shares fell 61.4% to $1.03 after the company said it has entered into a Restructuring Support Agreement with its principal secured lender, Lynrock Lake Master Fund LP, who will become the principal equity owner of CalAmp and take the Company private.</li>
<li>Ault Disruptive Technologies Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADRT#NASDAQ">ADRT</a>) fell 52.2% to $21.50.</li>
<li>CNS Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNSP#NASDAQ">CNSP</a>) fell 32.3% to $0.1463. CNS Pharmaceuticals announced a 1-for-50 reverse stock split.</li>
<li>Galera Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRTX#NASDAQ">GRTX</a>) fell 30% to $0.1536. Galera Therapeutics will be delisted by Nasdaq.</li>
<li>Portage Biotech Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRTG#NASDAQ">PRTG</a>) shares fell 29.7% to $0.3365 after gaining over 91% on Friday.</li>
<li>1847 Holdings LLC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EFSH#NYSE">EFSH</a>) dipped 29.5% to $0.7895.</li>
<li>FOXO Technologies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FOXO#NYSE">FOXO</a>) fell 26.3% to $0.3501.</li>
<li>iSpecimen Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISPC#NASDAQ">ISPC</a>) shares declined 24.4% to $0.3251.</li>
<li>Webuy Global Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WBUY#NASDAQ">WBUY</a>) fell 23.7% to $0.1870.</li>
<li>Direct Digital Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DRCT#NASDAQ">DRCT</a>) fell 21.2% to $2.67.</li>
<li>Vintage Wine Estates, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VWE#NASDAQ">VWE</a>) fell 19.2% to $0.2883.</li>
<li>Latam Logistic Properties, S.A. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LPA#NYSE">LPA</a>) fell 19.2% to $105.00</li>
<li>Brand Engagement Network, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BNAI#NASDAQ">BNAI</a>) shares fell 16.4% to $4.55 after jumping over 110% on Friday.</li>
<li>Lattice Semiconductor Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LSCC#NASDAQ">LSCC</a>) fell 15.1% to $63.00 after the company announced an interim CEO following Jim Anderson&#8217;s decision to step down as President, CEO and Board member to pursue an opportunity with another company.</li>
<li>Latam Logistic Properties, S.A. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LPA#NYSE">LPA</a>) dipped 13.8% to $112.00.</li>
<li>Digital Health Acquisition Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DHAC#NASDAQ">DHAC</a>) shares fell 10.3% to $15.25 after gaining 13% on Friday.</li>
<li>Grupo Aeroportuario del Centro Norte, S.A.B. de C.V. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OMAB#NASDAQ">OMAB</a>) declined 10.2% to $73.44.</li>
<li>Immunocore Holdings plc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IMCR#NASDAQ">IMCR</a>) fell 10.1% to $44.05.</li>
<li>Grupo Aeroportuario del Pacífico, S.A.B. de C.V. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PAC#NYSE">PAC</a>) fell 10% to $169.23.</li>
<li>GSK plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GSK#NYSE">GSK</a>) fell 8.7% to $40.87 after the company said it will appeal a ruling made by the Delaware State Court regarding its ongoing ranitidine litigation.</li>
<li>The Scotts Miracle-Gro Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SMG#NYSE">SMG</a>) declined 7.7% to $64.33.</li>
<li>ZIM Integrated Shipping Services Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZIM#NYSE">ZIM</a>) fell 7.7% to $20.81.</li>
<li>Dell Technologies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DELL#NYSE">DELL</a>) fell 7.1% to $129.63. On May 30, Dell reported upbeat earnings and sales results for the first quarter.</li>
<li>Vistra Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VST#NYSE">VST</a>) dipped 6.5% to $92.61.</li>
</ul>
The Boston Beer Company, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SAM#NYSE">SAM</a>) shares fell 4.7% to $299.07. Boston Beer shares jumped around 22% on Friday following a report suggesting the company is in talks to sell itself to Suntory. Boston Beer later issued a statement on the company sale speculation. "We are fully focused on our business as an independent company and our return to growth," the company said.
Now Read This: <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/06/39137769/this-mongodb-analyst-is-no-longer-bearish-here-are-top-5-upgrades-for-monday">This MongoDB Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Monday</a>

Intraday Update

ADRT

AFMD

BNAI

BPTH

CAMP

CGON

CNSP

COHR

CRKN

DELL

DHAC

DOGZ

DRCT

EFSH

FFIE

FOXO

GPCR

GRTX

IMCR

IPDN

ISPC

LQDA

LSCC

MBOT

MGNX

MOLN

NVAX

OLMA

Grupo Aeroportuario del Centro NorteB de CV

OMAB

PGEN

PRTG

PSNL

SAIC

Vintage Wine Estates, Inc. - Common Stock

WBUY

YGMZ

Why Science Applications International Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Waste Management, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WM#NYSE">WM</a>) stock is down Monday after the company announced plans <a href="https://www.benzinga.com/wiim/24/06/39138996/waste-management-shares-are-trading-lower-after-the-company-announced-that-it-entered-into-a-definit">to acquire Stericycle (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/srcl#NASDAQ">SRCL</a>).</a>
What Happened: Waste Management has entered into a definitive agreement to acquire Stericycle where the company will purchase all outstanding Stericycle shares at $62 a share, totaling to $7.2 billion.
Waste Management expects the acquisition to allow the company to expand its investment in North America&#8217;s recycling infrastructure. 
In addition, Stericycle&#8217;s acquisition enriches WM&#8217;s environmental solutions with assets in medical waste and secure information destruction sectors. The company anticipates more than $125 million in annual run-rate synergies and strong earnings as well as cash flow within one year of closing.
&#8220;At WM, we are committed to maximizing value for all our stakeholders by providing a comprehensive suite of environmental solutions to the market. The acquisition of Stericycle is a significant step in advancing this commitment because it broadens the scope of our service offerings, bringing together the leader in solid waste and a premier company in regulated medical waste services,&#8221; said Jim Fish, president and CEO of WM. 
&#8220;We have a proven track record of integrating and optimizing acquired businesses that benefit our customers and employees and deliver a strong return on investment for our shareholders. We look forward to working with the Stericycle team to capture the strategic, customer service, environmental, and financial benefits of this acquisition.&#8221;
The deal is expected to close as soon as the fourth quarter of 2024 subject to certain closing conditions, regulatory approvals and approval by a majority of Stericycle&#8217;s shareholders.
Related Link:<a href="https://www.benzinga.com/news/24/06/39139004/stericycle-marinemax-agios-pharmaceuticals-and-other-big-stocks-moving-higher-on-monday"> Stericycle, MarineMax, Agios Pharmaceuticals And Other Big Stocks Moving Higher On Monday</a>
WM Price Action: At the time of publication, Waste Management shares are down 3.94% at $202.42, according to data from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.
Image: 5669431 from Pixabay.

Why Waste Management Shares Are Trading Lower Monday

<h3>Gainers</h3>
<ul>
<li>MingZhu Logistics Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/YGMZ#NASDAQ">YGMZ</a>) stock rose 32.3% to $0.45 during Monday's regular session. The company's market cap stands at $16.6 million. </li>
<li>Ambipar Emergency (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/AMBI#AMEX">AMBI</a>) shares rose 25.07% to $4.44. The company's market cap stands at $246.1 million. </li>
<li>iPower (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IPW#NASDAQ">IPW</a>) shares increased by 17.16% to $2.73. The market value of their outstanding shares is at $81.4 million. </li>
<li>SolarMax Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMXT#NASDAQ">SMXT</a>) stock increased by 15.42% to $7.08. The company's market cap stands at $318.2 million. </li>
<li>Stericycle (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SRCL#NASDAQ">SRCL</a>) stock moved upwards by 14.84% to $59.19. The market value of their outstanding shares is at $5.4 billion. </li>
<li>Professional Diversity (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IPDN#NASDAQ">IPDN</a>) shares increased by 12.66% to $0.57. The market value of their outstanding shares is at $6.6 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>1847 Holdings (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/EFSH#AMEX">EFSH</a>) stock fell 23.2% to $0.86 during Monday's regular session. The market value of their outstanding shares is at $4.5 million. </li>
<li>Team (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TISI#NYSE">TISI</a>) stock declined by 15.12% to $7.28. The company's market cap stands at $32.1 million. </li>
<li>Wheels Up Experience (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UP#NYSE">UP</a>) shares decreased by 13.95% to $2.31. The company's market cap stands at $1.6 billion. </li>
<li>Nano Nuclear Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NNE#NASDAQ">NNE</a>) stock fell 12.52% to $6.54. The market value of their outstanding shares is at $189.2 million. </li>
<li>Science Applications Intl (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SAIC#NASDAQ">SAIC</a>) stock declined by 12.18% to $118.25. The company's market cap stands at $6.0 billion. As per the news, the Q1 earnings report came out today. </li>
<li>Volato Group (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/SOAR#AMEX">SOAR</a>) stock declined by 11.25% to $1.06. The market value of their outstanding shares is at $31.1 million. 
See Also: <a href="http://www.benzinga.com/money/best-industrials-stocks/" title="www.benzinga.com/money/best-industrials-stocks/">www.benzinga.com/money/best-industrials-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AMBI

SMXT

SOAR

TISI

12 Industrials Stocks Moving In Monday's Intraday Session

U.S. stocks were mixed, with the Dow Jones index falling around 100 points on Monday.
Shares of Stericycle, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SRCL#NASDAQ">SRCL</a>) rose sharply during Monday's session after the company inked a deal to be acquired by Waste Management Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WM#NYSE">WM</a>) for approximately $7.2 billion, including debt.
Stericycle shares climbed 15% to $59.28 on Monday.
Here are some other big stocks recording gains in today&#8217;s session.
<ul>
<li>GameStop Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GME#NYSE">GME</a>) shares jumped 34.5% to $31.13 after Roaring Kitty on a Reddit post, shared his position on the stock.</li>
<li>MarineMax, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HZO#NYSE">HZO</a>) jumped 27% to $36.16. OneWater Marine Inc. is reportedly said to be in advanced discussions to acquire MarineMax.</li>
<li>Liquidia Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LQDA#NASDAQ">LQDA</a>) shares jumped 16.8% to $15.03 as the company said District Court issued favorable ruling and denied United Therapeutics&#8217; request to block YUTREPIA&#x2122; launch.</li>
<li>Olema Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OLMA#NASDAQ">OLMA</a>) gained 15.5% to $11.18.</li>
<li>Agios Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AGIO#NASDAQ">AGIO</a>) gained 13.7% to $41.30 as the company reported Phase 3 results for mitapivat in reducing thalassemia transfusions.</li>
<li>Coherent Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COHR#NASDAQ">COHR</a>) rose 13.4% to $64.71 after the company announced the appointment of Jim Anderson as CEO.</li>
<li>CG Oncology, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGON#NASDAQ">CGON</a>) gained 11.8% to $36.34</li>
<li>Structure Therapeutics Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GPCR#NASDAQ">GPCR</a>) gained 11.8% to $38.25 after the company reported 12-week results for obesity drug GSBR-1290, achieving significant weight loss.</li>
<li>Intellia Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NTLA#NASDAQ">NTLA</a>) rose 11.8% to $23.9 after the company announced long-term data from the Phase 1 portion of the ongoing Phase 1/2 study of NTLA-2002..</li>
<li>AMC Entertainment Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMC#NYSE">AMC</a>) climbed 11.6% to $4.8330. The resumption of the meme rally came on the back of Keith Gill, also known as "Roaring Kitty," disclosing a substantial position in GameStop on the r/Superstonk Reddit forum.</li>
<li>Novavax, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVAX#NASDAQ">NVAX</a>) rose 10.7% to $16.65.</li>
<li>Twist Bioscience Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TWST#NASDAQ">TWST</a>) gained 9.8% to $45.99.</li>
<li>Geron Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GERN#NASDAQ">GERN</a>) climbed 9.2% to $3.8750.</li>
<li>Telephone and Data Systems, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TDS#NYSE">TDS</a>) climbed 9% to $21.67 as the company agreed to sell its wholly owned subsidiaries OneNeck IT Solutions and OneNeck Data Center to US Signal Company, LLC.</li>
<li>Arrowhead Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARWR#NASDAQ">ARWR</a>) rose 8.9% to $24.99 as the company reported topline results from pivotal Phase 3 PALISADE study of investigational plozasiran.</li>
<li>Summit Therapeutics Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMMT#NASDAQ">SMMT</a>) gained 8.8% to $9.45.</li>
<li>SkyWest, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SKYW#NASDAQ">SKYW</a>) jumped 8.4% to $80.97.</li>
<li>Autodesk, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADSK#NASDAQ">ADSK</a>) rose 8.3% to $218.39 after the company issued preliminary results and said there will be no restatement or adjustment of any audited or unaudited financial statements.</li>
<li>Denali Therapeutics Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DNLI#NASDAQ">DNLI</a>) jumped 8.1% to $20.06 as the company said that the FDA has selected DNL126 for participation in support for clinical trials advancing rare disease therapeutics pilot program.</li>
<li>Vera Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VERA#NASDAQ">VERA</a>) gained 7.3% to $40.75.</li>
<li>Paramount Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PARA#NASDAQ">PARA</a>) rose 7.1% to $12.76 following reports suggesting Skydance is poised to announce the takeover of Paramount.</li>
<li>e.l.f. Beauty, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ELF#NYSE">ELF</a>) gained 7% to $199.99. DA Davidson analyst Linda Bolton Weiser maintained e.l.f. Beauty with a Buy and maintained a $220 price target.</li>
<li>Arm Holdings plc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARM#NASDAQ">ARM</a>) rose 5% to $126.55 after the broader sector selloff on Friday when the U.S. government imposed sanctions on the Middle East regarding AI chips.</li>
</ul>
Now Read This: <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/06/39135495/20m-bet-on-this-energy-stock-check-out-these-3-stocks-insiders-are-buying">$20M Bet On This Energy Stock? Check Out These 3 Stocks Insiders Are Buying</a>

AGIO

ARWR

DNLI

GERN

NTLA

PARA

SKYW

SMMT

TWST

VERA

Stericycle, MarineMax, Agios Pharmaceuticals And Other Big Stocks Moving Higher On Monday

Stericycle, Inc.&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SRCL#NASDAQ">SRCL</a>) shares are trading higher after the company inked a deal to be acquired by Waste Management&nbsp;Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WM#NYSE">WM</a>) for&nbsp;<a target="_blank" href="https://www.benzinga.com/pressreleases/24/06/b39132848/wm-to-acquire-stericycle-a-leader-in-medical-waste-services-for-7-2-billion" rel="noreferrer noopener">approximately $7.2 billion, including debt</a>.
Stericycle focuses on the collection and disposal of hazardous medical waste and also operates a document shredding <a target="_blank" href="https://www.benzinga.com/markets/equities/24/06/39132054/waste-management-nears-7b-deal-to-acquire-stericycle-report" rel="noreferrer noopener">service known as Shred-It</a>.
As per the terms, the per-share cash acquisition price is $62.00, which represents a premium of 24% to Stericycle&#8217;s 60-day volume-weighted average price as of May 23, 2024 (the last trading day before an article reported that Stericycle was considering a potential sale). The acquisition price represents a premium of 20% to SRCL&#8217;s previous closing price of $51.54.
The deal is unanimously approved by the boards of directors of both companies and is expected to close as early as the fourth quarter of 2024, subject to customary closing conditions.
Jim Fish, President and Chief Executive Officer of Waste Management, said, &#8220;The acquisition of Stericycle is a significant step in advancing this commitment because it broadens the scope of our service offerings, bringing together the leader in solid waste and a premier company in regulated medical waste services.&#8221;
Financial Benefits: Waste Management expects the deal to generate annual run-rate synergies of over $125 million and be accretive to earnings and cash flows within one year of closing.
In the near term, post-buyout completion, Waste Management expects to achieve a net debt-to-EBITDA ratio of approximately 3.4x and a leverage ratio within its targeted net debt-to-EBITDA range of 2.75x to 3.0x approximately 18 months after closing the transaction.
Both companies remain confident in the strength of their businesses and expect to achieve previously announced full-year guidance, excluding the impacts of any transaction-related costs.
Waste Management intends to finance the transaction using a combination of bank debt and senior notes. As of March-end, WM&#8217;s cash and <a target="_blank" href="https://www.benzinga.com//node/38418437" rel="noreferrer noopener">equivalents stood at $322 million</a>.
Waste Management stock has gained more than 25% in the last 12 months. Investors can gain exposure to the stock via IShares U.S. Utilities ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IDU#NYSE">IDU</a>) and TCW Transform Systems ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NETZ#NYSE">NETZ</a>).
Also Read: <a target="_blank" href="https://www.benzinga.com/markets/equities/24/05/38891801/waste-management-mulls-3b-sale-of-rng-business-report" rel="noreferrer noopener">Waste Management Mulls $3B Sale Of RNG Business: Report</a>
Price Action: SRCL shares are up 15% at $59.27 at the last check Monday.
Photo via Shutterstock

Large Cap

Mid Cap

Engine No. 1 ETF Trust Engine No. 1 Transform Climate ETF

NETZ

Waste Management To Acquire Stericycle For $62.00/Share In Cash, At 20% Premium

<h3>Gainers</h3>
<ul>
<li>MingZhu Logistics Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/YGMZ#NASDAQ">YGMZ</a>) shares moved upwards by 57.8% to $0.54 during Monday's pre-market session. The company's market cap stands at $19.9 million. </li>
<li>Earlyworks Co (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ELWS#NASDAQ">ELWS</a>) shares moved upwards by 20.18% to $2.56. The market value of their outstanding shares is at $7.7 million. </li>
<li>Jayud Global Logistics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JYD#NASDAQ">JYD</a>) shares moved upwards by 19.11% to $0.81. The market value of their outstanding shares is at $17.2 million. </li>
<li>Stericycle (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SRCL#NASDAQ">SRCL</a>) stock increased by 16.22% to $59.9. The market value of their outstanding shares is at $5.5 billion. </li>
<li>Pineapple Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PEGY#NASDAQ">PEGY</a>) shares increased by 10.52% to $0.21. The market value of their outstanding shares is at $22.7 million. </li>
<li>Professional Diversity (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IPDN#NASDAQ">IPDN</a>) stock rose 8.89% to $0.55. The company's market cap stands at $6.4 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>1847 Holdings (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/EFSH#AMEX">EFSH</a>) stock fell 12.7% to $0.98 during Monday's pre-market session. The company's market cap stands at $5.1 million. </li>
<li>Knightscope (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KSCP#NASDAQ">KSCP</a>) stock decreased by 10.39% to $0.26. The company's market cap stands at $27.3 million. </li>
<li>Graphex Gr (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/GRFX#AMEX">GRFX</a>) stock decreased by 8.47% to $0.34. The market value of their outstanding shares is at $15.1 million. </li>
<li>Quhuo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QH#NASDAQ">QH</a>) shares fell 5.68% to $0.5. The market value of their outstanding shares is at $5.1 million. </li>
<li>Controladora Vuela (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VLRS#NYSE">VLRS</a>) stock fell 5.02% to $7.57. The company's market cap stands at $871.6 million. </li>
<li>Sentage Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNTG#NASDAQ">SNTG</a>) shares fell 4.27% to $2.12. The company's market cap stands at $5.9 million. 
See Also: <a href="http://www.benzinga.com/money/best-industrials-stocks/" title="www.benzinga.com/money/best-industrials-stocks/">www.benzinga.com/money/best-industrials-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ELWS

GRFX

KSCP

PEGY

SNTG

VLRS

12 Industrials Stocks Moving In Monday's Pre-Market Session

WIIM

Stericycle shares are trading higher after the company announced that it entered into a definitive agreement to be acquired by Waste Management.

Trading Halt: Halt status updated at 7:30:00 AM ET: Quotation Resumption: News and Resumption Times

Truist raised the firm's price target on WM (WM) to $250 from $235 and keeps a Buy rating on the shares. The company reported upside Q3 results and...

WM price target raised to $250 from $235 at Truist

Stericycle gains after disclosing all approvals for Waste Management deal done

Stericycle gains after disclosing all approvals for Waste Management deal done (update)

In a regulatory filing, Waste Management (WM) disclosed that on October 30, the company and Stericycle (SRCL) received requisite approval for the c...

WM, Stericycle expect to complete merger on November 4

Chewy (CHWY) will replace Stericycle (SRCL) in the S&P MidCap 400 effective prior to the opening of trading on Wednesday, November 6. S&P 500 const...

Chewy to replace Stericycle in the S&P 400 at open on 11/6

Stericycle ( ($SRCL) ) has released its Q3 earnings. Here is a breakdown of the information Stericycle presented to its investors. Stericycle, Inc....

Stericycle Reports Q3 2024 Financial Results

M&A deals roundup: AbbVie, Blackstone, Take-Two Interactive and more

Truist Financial analyst Tobey Sommer maintained a Hold rating on Stericycle (SRCL – Research Report) today. The company's shares closed last Frida...

Stericycle (SRCL) Receives a Rating Update from a Top Analyst

The latest update is out from Stericycle ( ($SRCL) ). In a significant financial move, Stericycle has fully repaid and terminated its $1.04 billion...

Stericycle Completes Major Merger and Structural Overhaul

In a report released on November 1, David Manthey from Robert W. Baird maintained a Hold rating on Stericycle (SRCL – Research Report), with a pric...

Stericycle's Financial Challenges Prompt Hold Rating Amid Pending Acquisition

ABBV

ALTR

AMKBY

AVTE

GLYC

SIEGY

SMAWF

STZHF

TRUE

TTWO

Press Releases

Greenwave Technology Solutions (GWAV) Sets New Record in Car Recycling, Expands AI Integration

STERICYCLE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Stericycle, Inc. - SRCL

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SRCL, IBTX, AGS, SRDX on Behalf of Shareholders

Commodities

Stericycle Recognized by Newsweek as One of America's Greatest Workplaces and Greatest Workplaces for Mental Wellbeing in 2024

Stericycle and Arbor Day Foundation Celebrate Third Year of Partnership

Stericycle Recognized by TIME and Statista as One of America's Best Midsize Companies

Stericycle Opens State-of-the-Art Regulated Medical Waste Incineration Facility in Nevada

Comments

Stericycle, Inc. - Common Stock

Notizie

Ultime notizie per Stericycle, Inc. - Common Stock (NASDAQ:SRCL) Azioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO